Comparison of venetoclax plus rituximab with B-cell receptor inhibitors in patients with relapsed/refractory chronic lymphocytic leukemia: a systematic review and network Meta-analysis. Leukemia & lymphoma Molica, S., Giannarelli, D., Shanafelt, T. D. 2019: 1–4

View details for DOI 10.1080/10428194.2019.1691193

View details for PubMedID 31724894